What is the official website of Gamida Cell Ltd. ?

The official website of Gamida Cell Ltd. is http://www.gamida-cell.com.

What is Gamida Cell Ltd.'s cybersecurity risk score?

Gamida Cell Ltd. has an AI-generated cybersecurity risk score of 746 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has Gamida Cell Ltd. experienced?

According to Rankiteo, Gamida Cell Ltd. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Gamida Cell Ltd. been affected by any supply chain cyber incidents ?

According to Rankiteo, Gamida Cell Ltd. has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Gamida Cell Ltd. have SOC 2 Type 1 certification ?

According to Rankiteo, Gamida Cell Ltd. is not certified under SOC 2 Type 1.

Does Gamida Cell Ltd. have SOC 2 Type 2 certification ?

According to Rankiteo, Gamida Cell Ltd. does not hold a SOC 2 Type 2 certification.

Does Gamida Cell Ltd. comply with GDPR ?

According to Rankiteo, Gamida Cell Ltd. is not listed as GDPR compliant.

Does Gamida Cell Ltd. have PCI DSS certification ?

According to Rankiteo, Gamida Cell Ltd. does not currently maintain PCI DSS compliance.

Does Gamida Cell Ltd. comply with HIPAA ?

According to Rankiteo, Gamida Cell Ltd. is not compliant with HIPAA regulations.

Does Gamida Cell Ltd. have ISO 27001 certification ?

According to Rankiteo,Gamida Cell Ltd. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Gamida Cell Ltd. operate in ?

Gamida Cell Ltd. operates primarily in the Biotechnology Research industry.

How many employees does Gamida Cell Ltd. have ?

Gamida Cell Ltd. employs approximately 94 people worldwide.

Does Gamida Cell Ltd. own any subsidiaries ?

Gamida Cell Ltd. presently has no subsidiaries across any sectors.

How many LinkedIn followers does Gamida Cell Ltd. have ?

Gamida Cell Ltd.'s official LinkedIn profile has approximately 11,571 followers.

What is the NAICS classification code for Gamida Cell Ltd. ?

Gamida Cell Ltd. is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Gamida Cell Ltd. have a Crunchbase profile ?

Yes, Gamida Cell Ltd. has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/gamida-cell.

Does Gamida Cell Ltd. have a LinkedIn profile ?

Yes, Gamida Cell Ltd. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/gamida-cell-ltd-.

How many cybersecurity incidents has Gamida Cell Ltd. experienced ?

As of September 18, 2026, Rankiteo reports that Gamida Cell Ltd. has not experienced any cybersecurity incidents.

How many peer or competitor companies does Gamida Cell Ltd. have ?

Gamida Cell Ltd. has an estimated 4,766 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

GCL

Boost Score +25 with badge (5 left)

746

/1000

Moderate

771

/1000

Fair

Gamida Cell Ltd. Vendor Cyber Rating & Cyber Score

gamida-cell.com

cb in

Add Your Compliance Badge

Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Our proprietary nicotinamide (NAM) technology expands the number of cells while maintaining their intrinsic properties to create potentially curative cell therapy products and candidates for patients with cancer. Our stem cell transplant therapy was approved by the US FDA in April 2023. Clinical study of our NK cell therapy candidate GDA-201 is ongoing.

GCL

Gamida Cell Ltd. CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

GCL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for GCL

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Gamida Cell Ltd. in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Gamida Cell Ltd. in 2026.

Incident Types GCL vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Gamida Cell Ltd. in 2026.

Incident History - GCL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Gamida Cell Ltd. Subsidiaries

Parent Company

GCL

Biotechnology Research

Website: http://www.gamida-cell.com

Company Size: 51-200 employees

No subsidiary data available for this company.

Loading…

Gamida Cell Ltd. Similar Companies

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

Loading…

NEWS

Gamida Cell Ltd. CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management

Company expected to receive significant new capital from Highbridge to bolster the commercialization of allogeneic stem cell transplant ...

Read Article

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update · In 2023, a total of 17 transplant centers ...

Read Article

BioLineRx Lands $10M Deal with Ayrmid for APHEXDA, Plus $87M in Milestone Potential

This licensing deal marks a significant strategic shift for BioLineRx, bringing in immediate capital through a $10 million upfront payment and ...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-93436

SUMMARY

vLLM through 0.29.0 fails to properly clean up decode-side metadata for rejected inference requests in prefill/decode disaggregated deployments. Remote attackers can submit requests with max_tokens=0 to exhaust decode-worker memory without bound until the worker restarts.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-93435

SUMMARY

redis-parser through 3.0.0 contains a denial of service vulnerability in the RESP protocol parser that allows malicious Redis endpoints to crash the client process through unbounded recursion on nested arrays. Attackers can send crafted RESP byte streams with repeated array headers that exhaust the V8 call stack, causing an uncaught RangeError that terminates the Node.js process without triggering error handling callbacks.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-87701

SUMMARY

Improper neutralization of special elements in output used by a downstream component ('injection') in Azure Cosmos DB allows an authorized attacker to elevate privileges over a network.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 9.6)

cvss3

Base Score: 9.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:N

Impact Score

5.8

Exploitability

3.1

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-87701

CVE-2026-85917

SUMMARY

Server-side request forgery (ssrf) in Azure AI Foundry allows an unauthorized attacker to elevate privileges over a network.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-85917

CVE-2026-85889

SUMMARY

Missing authentication for critical function in Azure AI Foundry allows an unauthorized attacker to elevate privileges over a network.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 10)

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

Impact Score

Exploitability

3.9

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-85889

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Gamida Cell Ltd. Vendor Cyber Rating & Cyber Score

GCL A.I CyberSecurity Scoring

Gamida Cell Ltd. CyberSecurity News & History

GCL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for GCL

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types GCL vs Biotechnology Research Industry Avg (This Year)

Incident History - GCL (X = Date, Y = Severity)

Gamida Cell Ltd. Subsidiaries

Parent Company

GCL

Gamida Cell Ltd. Similar Companies

Gilead Sciences

Roche

The National Institutes of Health

Eurofins

Thermo Fisher Scientific

ICON plc

Charles River Laboratories

Genentech

Fortrea

Gamida Cell Ltd. CyberSecurity News

Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update

BioLineRx Lands $10M Deal with Ayrmid for APHEXDA, Plus $87M in Milestone Potential

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Gamida Cell Ltd. CyberSecurity News & History

GCL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for GCL

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types GCL vs Biotechnology Research Industry Avg (This Year)

Incident History - GCL (X = Date, Y = Severity)

Gamida Cell Ltd. Subsidiaries

Parent Company

GCL

Gamida Cell Ltd. Similar Companies

Gilead Sciences

Roche

The National Institutes of Health

Eurofins

Thermo Fisher Scientific

ICON plc

Charles River Laboratories

Genentech

Fortrea

Gamida Cell Ltd. CyberSecurity News

Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update

BioLineRx Lands $10M Deal with Ayrmid for APHEXDA, Plus $87M in Milestone Potential

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo